Owner graduated with PhD from National University of Singapore (NUS) Medical School and currently working as a Research Scientist with government linked institute. Had published many papers on Cancer Research with world top tier Journals.
Owner recently completed stage one research on Cancer Immunotherapy showing excellent results in mouse models with patented technology. Owner looking for SGD $25 million dollars for trial run of this product on human cancer patients over the next 3 to 4 years in USA. Upon the successful completion of the second stage trial run at USA, will seek the approval of FDA for use of this product to human patients all over the world.
If successful, will be able to work with some of the world top pharmaceutical companies to market this product all over the world. Hope to achieve 50 times or more (>SGD $1 billion) of the investment returns. However, the investors need to have high risk appetite for such kind of investment.
For more information, please contact the below: Pls WhatsApp Mr P C Ang @93864082
Singapore 
